Answer
Ritlecitinib tosylate reduces the cytolytic activity of NK cells and CD8+ T cells by irreversibly and selectively inhibiting TEC-family kinases through blockade of their adenosine triphosphate (ATP) binding site.
Sources for this answer
- Litfulo 50mg hard capsulesPfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated
Sources checked